Shuttle Pharmaceuticals Holdings (SHPH) Invested Capital (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Invested Capital history runs 6 years deep, the most recent figure standing at $7.8 million for Q1 2026.

• In Q1 2026, Invested Capital rose 135.26% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (up 135.26% YoY), while the FY2025 annual figure was $6.7 million, up 810.96% from the prior year.
• Invested Capital was $7.8 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $6.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $8.4 million in Q3 2022 to a low of -$2.3 million in Q2 2022.
• Historically, Invested Capital has averaged $3.7 million across 5 years, with a median of $3.6 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Invested Capital sank 122.07% in 2024, then surged 810.96% in 2025.
• A 5-year view of Invested Capital shows it stood at $7.7 million in 2022, then plunged by 47.13% to $4.1 million in 2023, then plunged by 81.91% to $734433.0 in 2024, then soared by 810.96% to $6.7 million in 2025, then grew by 16.32% to $7.8 million in 2026.
• The last three Invested Capital figures came in at $7.8 million (Q1 2026), $6.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.